分布式成本效果评价方法及研究现状  

Introduction and Application Status of Distributional Cost-effectiveness Analysis

作　　者：湛浩然 胡玉瑶 孙雨馨 苏宇 孙宇馨 李尚尧 田雨 徐婷婷 ZHAN Haoran;HU Yuyao;SUN Yuxin;SU Yu;SUN Yuxin;LI Shangyao;TIAN Yu;XU Tingting(School of Public Health,Capital Medical University,Beijing 100069,China;不详)

机构地区：[1]首都医科大学公共卫生学院,北京100069

出　　处：《卫生经济研究》2023年第9期85-90,共6页

基　　金：首都医科大学科研培育基金“基于Markov模型的北京市结直肠癌筛查方案卫生经济学评估研究”(校社科-常规项目PYS2101)。

摘　　要：目的:介绍分布式成本效果评价方法,为我国开展纳入公平性考量的经济学评价研究提供参考。方法:介绍分布式成本效果评价的步骤和关键概念,梳理研究现状及局限。结果:目前分布式成本效果评价研究处于起步阶段,对“公平”缺乏规范定义、亚组数据可及性较差以及异质性等问题是限制该方法推广和应用的主要原因。结论:需要从多方面改善分布式成本效果评价的基础,推进纳入公平性考量的经济学评价研究。Objective To introduce the method of distributional cost-effectiveness analysis,and to provide reference for the development of economic evaluation with considerations of fairness in China.Methods The steps and key concepts of distributional cost-effectiveness analysis are introduced in detail,and the application status and limitations are summarized.Results At present,the application of distributed cost-effectiveness analysis is still at beginning.The lack of normative definition of fairness,poor accessibility of subgroup data and high heterogeneity are the main reasons that limit the promotion and application of distributional cost-effectiveness analysis.Conclusion It is necessary to improve the information base of distributional cost-effectiveness analysis from various aspects,so as to promote economic evaluation research that takes fairness into consideration.

关 键 词：分布式成本效果评价 公平性 经济学评价 成本效果评价 

分 类 号：R19[医药卫生—卫生事业管理]